Mumbai, Aug. 17 -- Sun Pharmaceutical Industries and certain of its subsidiaries have been defendants in antitrust litigation in the United States relating to a 2008 patent litigation settlement agreement with Pfizer concerning generic Lipitor (Atorvastatin).

Published by HT Digital Content Services with permission from Capital Market....